SLDB - Solid Biosciences Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5308.38M
Enterprise Value 3124.99M
Trailing P/E N/A
Forward P/E 1-3.75
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)3.11
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-1.42

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 3-76.83%
S&P500 52-Week Change 30.90%
52 Week High 354.54
52 Week Low 34.32
50-Day Moving Average 36.04
200-Day Moving Average 37.73

Share Statistics

Avg Vol (3 month) 3516.32k
Avg Vol (10 day) 31.06M
Shares Outstanding 535.41M
Float 3.61M
% Held by Insiders 134.71%
% Held by Institutions 177.40%
Shares Short (Jul 15, 2019) 43.64M
Short Ratio (Jul 15, 2019) 48.79
Short % of Float (Jul 15, 2019) 421.41%
Short % of Shares Outstanding (Jul 15, 2019) 410.28%
Shares Short (prior month Jun 14, 2019) 42.54M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-36.36%
Return on Equity (ttm)-63.66%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -88.08M
Net Income Avi to Common (ttm)-88.5M
Diluted EPS (ttm)-2.56
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)94.74M
Total Cash Per Share (mrq)2.68
Total Debt (mrq)8.01M
Total Debt/Equity (mrq)8.08
Current Ratio (mrq)6.99
Book Value Per Share (mrq)2.80

Cash Flow Statement

Operating Cash Flow (ttm)-78.95M
Levered Free Cash Flow (ttm)-56.27M